MEDNAX, INC. 4
4 · MEDNAX, INC. · Filed Jun 3, 2015
Insider Transaction Report
Form 4
Clark David A.
COO / Pediatrix Division
Transactions
- Award
Common Stock
2015-06-01+9,615→ 36,221 total - Sale
Common Stock
2015-06-01$70.48/sh−14,654$1,032,783→ 21,567 total
Footnotes (3)
- [F1]Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2016, June 1, 2017 and June 1, 2018.
- [F2]Sales made pursuant to Reporting Person's 10b5-1 trading plan.
- [F3]Sales of shares were made in seventy-six (76) separate transactions with prices ranging from $70.07 to $71.05 for a weighted average sales price of $70.4779.